-
Posted by
Two Blokes Apr 19 -
Filed in
Stock
-
5 views
Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland , April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync\u2122 sensor for use with the MiniMed\u2122 780G system. With this approval, the MiniMed\u2122 780G system now offers more flexibility for users of the company's most advanced insulin delivery system featuring Meal Detection\u2122 technology with both the Guardian\u2122 4 sensor and Simplera Sync\u2122 sensor.
